Please note that the video has been divided into chapters to facilitate navigation between presentations.
- Welcome words from the EU-ToxRisk project coordinator - Bob van de Water (Leiden University) PDF ; VIDEO
- Opening remarks on the EU-ToxRisk project, an EC Horizon 2020 initiative - Christian Desaintes (EC DG Research & Innovation) PDF ; VIDEO
Part I : New technologies and approaches for toxicology
- How has EU-ToxRisk impacted on innovative science research outreach - Thomas Steger Hartmann (Bayer) PDF ; VIDEO
- iPSC-derived hepatocyte spheroids for liver disease and toxicity assessment - Catherine Verfaillie (University Leuven) PDF ; VIDEO
- Biology-inspired microphysiological systems: the asset of multi-organ co-cultures - Uwe Marx (TissUse) PDF ; VIDEO
- Interactions with the Tox21 program - Joshua Harrill (U.S. EPA) PDF ; VIDEO
- The case of a high-concern toxicity profile screening - Bob van de Water (Leiden University) PDF ; VIDEO
- Application of NAMs to detect multisite metabolism - Paul Jennings (VU University Amsterdam) PDF
- Application of an AOP approach in a RAx safety assessment: the case of mitochondrial complex I inhibitors - Marcel Leist (University of Konstanz) PDF ; VIDEO
- Which NAM testing scope is good enough for risk identification/characterization? - Sylvia Escher (ITEM Fraunhofer) VIDEO
Part II: Implementation of NAM-based approaches in risk assessment workflows
- How has EU-ToxRisk impacted on NAM implementation in industry? - Andrew White (Unilever) PDF ; VIDEO
- A case study combining read-across and NAM, the example of propyl-paraben in systemic toxicity, from A to Z - Gladys Ouedraogo (L’Oreal)
- Commercialization Platform: perspectives from partners - Barry Hardy (Edelweiss Connect) PDF ; VIDEO
- Podium discussion: an overview on the impact of the EU-ToxRisk strategy from different perspectives - I. Cotgreave, T. S-Hartmann, M. Sachana, G. Kass, C. Desaintes VIDEO